Ultragenyx Pharmaceutical (RARE) Q2 2023 Earnings

4MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-3.5
-2.91
-2.33
-1.74

Details

Expected EPS
-2.04
Actual EPS
-2.33
Surprise EPS
-0.29
Surprise Percent
+14.22%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.33 per share for Q2 2023.

0 Comments

Share your thoughts